Literature DB >> 26125891

Association between interleukin gene polymorphisms and risk of recurrent oral ulceration.

C Jing1, J-Q Zhang2.   

Abstract

We conducted a case-control study to investigate the association between the functional IL-1β+3954 (C/T), IL-6-174 (G/C), IL-10-1082 (G/A), and IL-10-819C/T genetic polymorphisms and risk of recurrent oral ulceration (ROU) in a Chinese population. Polymorphisms of IL-1β+3954C/T, IL-6-174G/C, IL-10-1082A/G and IL-10-819C/T were assessed by polymerase chain reaction-restriction fragment length polymorphism. The genotype distributions of the IL-1β+3954 C/T and IL-10-819C/T were in Hardy-Weinberg equilibrium in the control group. Conditional logistic regression analyses showed that subjects carrying the IL-1β+3954CC and IL-10-1082AA genotypes had a significantly increased risk of ROU, with adjusted ORs (95%CI) of 2.86 (1.37-6.33) and 1.72 (1.02-2.89), respectively. In summary, we found that IL-1β+3954C/T and IL-10-1082A/G polymorphisms are associated with an increased risk of ROU.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26125891     DOI: 10.4238/2015.June.18.26

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  3 in total

1.  Interleukin-6 gene polymorphism in Saudi population with recurrent aphthous stomatitis.

Authors:  Samah Jameel Saeed Shabana; Muhammad Hamid Zaini Mutawakkil; Hassan Mamdouh Aly El-Ashmaoui; Fathya Mohammed Abdel-Qawi Zahran
Journal:  Saudi Dent J       Date:  2021-07-23

2.  Relationships of interleukin-17 polymorphisms with recurrent aphthous ulcer risk in a Han Chinese population.

Authors:  Haidong Xiang; Dongmei Cheng; Han Guo; Yan Wang; Zhiyu Jia; Qi Gao
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

3.  Salivary metabolomics profile of patients with recurrent aphthous ulcer as revealed by liquid chromatography-tandem mass spectrometry.

Authors:  Yantao Li; Daoming Wang; Chunwei Zeng; Yichen Liu; Guangyuan Huang; Zhanlong Mei
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.